Ultrasound Features of Polycystic Ovaries and Syndrome X: A Pilot Study
The aim of this study was to determine whether ultrasound features of polycystic ovaries (PCO) are associated with Metabolic Syndrome (MetS), a condition linked with an increased risk of vascular events.
A total of 66 women had ultrasound scans of their ovaries. There was no significant difference in the prevalence of MetS among women with unilateral or bilateral ultrasound evidence of PCO compared with women with no ultrasound evidence of PCO.
The finding of PCO alone on ultrasound may be of no metabolic significance and a poor screening tool for cardiovascular risk. Resources should be shifted from the current emphasis on ultrasound diagnosis of PCO Syndrome to improved endocrine and metabolic characterisation and treatment. This approach may, in turn, identify those women at highest risk of vascular events.
A total of 66 women had ultrasound scans of their ovaries. There was no significant difference in the prevalence of MetS among women with unilateral or bilateral ultrasound evidence of PCO compared with women with no ultrasound evidence of PCO.
The finding of PCO alone on ultrasound may be of no metabolic significance and a poor screening tool for cardiovascular risk. Resources should be shifted from the current emphasis on ultrasound diagnosis of PCO Syndrome to improved endocrine and metabolic characterisation and treatment. This approach may, in turn, identify those women at highest risk of vascular events.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics
Keywords: bmi; echogenic ovarian stroma; high density lipoprotein; metabolic syndrome (mets); plasminogen activator system; polycystic ovary syndrome; syndrome x; transvaginal or abdominal ultrasound scans; ultrasound
Document Type: Review Article
Affiliations: School of Human Development, University of Nottingham, Queens Medical Centre, Clifton Boulevard, Nottingham UK, NG7 2UH.
Publication date: 01 November 2004
- Vascular Disease Prevention publishes reviews as well as original papers to update all those concerned with this topic at the clinical or scientific level. In addition to clinically relevant topics, we consider reviews and original papers dealing with the more scientific aspects of vascular disease prevention. This includes the evaluation of emerging vascular risk factors, research dealing with the pathogenesis of atherosclerosis and the investigation of new treatment options both at the clinical and scientific level (e.g. epidemiology, patient-based studies, experimental models, in vitro experiments or molecular research). Therefore, another function of Vascular Disease Prevention is to bridge the gap between clinical practice and ongoing laboratory-based research.
In particular, we welcome critical reviews and comments on recent trials. This is a topic that requires regular updates because of the large number of trials published every year.
Debates are encouraged in the correspondence section of this journal.
The editorial structure of Vascular Disease Prevention is set up with the aim of dealing with the submitted material as rapidly as possible. Specialist editors will provide a more expert and rapid assessment unlike a more centralized editorial structure.
Receive new issue alert